1[1]Balkau B, Charles MA. Comments on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance. Diabetic Med 1999;16:442-443.
2[2]Third report of the national cholesterol education program (NCEP) expert panel on detection, envaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ). Final report. Circul 2002;106:3143-3421.
3[4]Naveed Sattar, Allan Gaw. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland: coronary prevention study. Circul 2003;108(4):414-419.
4[5]Nakanishi N, Takatorige T. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract 2004;64(1):59-70.
5[6]Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition 2004 ;20(5) :482-491.
6[7]Tan CE, Ma S. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004 May; 27 (5):1182-1186.
7[8]Caballero E. Obesity, diabetes, and the metabolic syndrome:new challenges in antipsychotic drug therapy. CNSSpectr 2003;8(11 Suppl2) :19-22.
8[9]Sonnenberg GE, Krakower GR. A novel pathway to the anifestations of metabolic syndrome. Obes Res 2004; 12 (2):180-186.
9[10]Osano GM, Vitale C. The metabolic syndrome in women:implications for therapy. Int J Clin Pract Suppl 2004 Mar;139(3) :20-25.
10[11]Laaksonen DE, Niskanen L. Testosterone and sex hormonebinding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004; 27 (5): 1036-1041.
